IBIO

Value Q1, 25Q2, 25Q3, 25 TTM Total revenue 100 K00 300 K Gross profit 100 K00 300 K Operating expenses 6.05 M9.45 M8.37 M 29.26 M Selling/general/admin expenses 2.5 M5.17 M5.11 M 14.95 M Research & development 3.55 M4.28 M3.25 M 14.31 M Operating income -5.95 M-9.45 M-8.37 M -28.96 M Non-Operating Income, Total 231 K452 K635 K 1.35 M Interest expense, net of interest capitalized 36 K41 K22 K 143 K Non-Operating Income, excl. Interest Expenses 231 K452 K635 K 1.35 M Unusual income/expense ——— — Pretax income -5.76 M-9.03 M-7.75 M -27.75 M Equity in earnings ——— — Taxes 000 0 Non-controlling/minority interest ——— — After tax other income/expense ——— — Net income before discontinued operations -5.72 M-8.99 M-7.73 M -23.07 M Discontinued operations ——— — Net income -5.72 M-8.99 M-7.73 M -27.61 M Dilution adjustment ——— — Preferred dividends ——— — Diluted net income available to common stockholders -5.67 M-8.99 M-7.73 M -27.56 M Basic earnings per share (Basic EPS) -0.11-0.09-0.06 -0.58 Diluted earnings per share (Diluted EPS) -0.11-0.09-0.06 -0.58 Average basic shares outstanding 52.98 M99.13 M119.6 M — Diluted shares outstanding 52.98 M99.13 M119.6 M — EBITDA 3.24 M-9.3 M-8.21 M -19.27 M EBIT -5.95 M-9.45 M-8.37 M -28.96 M Cost of revenue ——— — Other cost of goods sold ——— — Depreciation & amortization (cash flow) 9.19 M146 K152 K 9.69 M